LOINC display name : Lymph node involvement Ql (Lymph node);
LOINC long common name : Lymph node involvement;
LOINC short name : LN involved LN Ql;
LOINC description : Patients are allocated into two risk groups based on lymph node involvement; the risk
group for node-negative patients, and the risk group for node-positive (1-3) patients.
This term was created for, but not limited in use to, the Prosigna Breast Cancer Prognostic
Gene Signature assay, which is based on the reported 50-gene classifier algorithm
originally named PAM50.;
Has component